Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.
Gaucher disease (GD) patients often present with abnormalities in immune response that may be the result of alterations in cellular and/or humoral immunity. However, how the treatment and clinical features of patients impact the perturbation of their immunological status remains unclear. To address...
Main Authors: | Renuka Pudi Limgala, Chidima Ioanou, Matthew Plassmeyer, Mark Ryherd, Lina Kozhaya, Lauren Austin, Cem Abidoglu, Derya Unutmaz, Oral Alpan, Ozlem Goker-Alpan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5152900?pdf=render |
Similar Items
-
Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease
by: Renuka P. Limgala, et al.
Published: (2020-03-01) -
Optimal therapy in Gaucher disease
by: Ozlem Goker-Alpan
Published: (2010-07-01) -
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases.
by: Margarita M Ivanova, et al.
Published: (2019-01-01) -
Characteristics of 26 patients with type 3 Gaucher disease: A descriptive analysis from the Gaucher Outcome Survey
by: Ida Vanessa D. Schwartz, et al.
Published: (2018-03-01) -
The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease
by: Margarita M. Ivanova, et al.
Published: (2024-04-01)